Tivic Health Systems Inc. (TIVC)
| Bid | 4.33 |
| Market Cap | 2.81M |
| Revenue (ttm) | 780K |
| Net Income (ttm) | -5.66M |
| EPS (ttm) | -19.67 |
| PE Ratio (ttm) | -0.23 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 4.49 |
| Volume | 75,870 |
| Avg. Volume (20D) | 1,886,060 |
| Open | 4.36 |
| Previous Close | 4.36 |
| Day's Range | 4.23 - 4.78 |
| 52-Week Range | 2.43 - 31.45 |
| Beta | 2.16 |
About TIVC
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, includ...
1 month ago · seekingalpha.com
Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call TranscriptTivic Health Systems, Inc. (NASDAQ:TIVC ) Q4 2024 Results Conference Call March 21, 2025 4:30 PM ET Company Participants Jennifer Ernst - Chief Executive Officer Lisa Wolf - Interim Chief Financial Of...
2 months ago · businesswire.com
Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus NerveFREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and r...
